Acyclovir News
5 things you didn't know about genital herpes - MiamiHerald.com
According to the American Red Cross, individuals taking antiviral medication (acyclovir, valacyclovir, famciclovir) will need to wait 48 hours after their ...
Drug doesn't cut HIV risk - Seattle Times
By Sandi Doughton In another setback for AIDS research, Seattle scientists reported Monday that use of the drug acyclovir to treat people with genital ...
Anticipated 'slam dunk' AIDS treatment fails - San Francisco Chronicle
The assumption was simple: Use acyclovir, a proven anti-herpes drug, to knock down that infection, and the odds of avoiding HIV would dramatically improve ...
Disappointing news in fight against HIV - Kansas City Star
all 92 news articles
Genetic link to HSV offers new targets for drug development - Pharmaceutical Business Review
The current market leader in this treatment category is GSK, which markets both Zovirax (acyclovir) and its successor Valtrex (valacyclovir). ...
BioAlliance Pharma Announces a 786% Increase in Revenues for the ... - Business Wire (press release)
all 12 news articles
BioAlliance Pharma Publishes Its 2008 Financial Calendar and ... - WELT ONLINE
In addition, two other innovative products are currently in Phase III clinical trials: acyclovir Lauriad® in oral herpes (based on the same Lauriad® ...
BioAlliance Pharma will move into new premises in February 2008. - Ad-Hoc-News (Pressemitteilung)
In addition, two other innovative products are currently in Phase III clinical trials: acyclovir Lauriad® in oral herpes (based on the same Lauriad® ...
BioAlliance Pharma Receives Market Approval for Loramyc® in the ... - Nanotechnology News (press release)
In addition, two other innovative products are currently in Phase III clinical trials: acyclovir Lauriad® in oral herpes (based on the same Lauriad® ...
BioAlliance buccal tab making way across EU - LabTechnologist.com
A near term follow-on acyclovir product for oral herpes is currently in clinical trials, and a fentanyl product for treatment of severe resistant cancer ...
Acyclovir RSS Feed